Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens (Q33331172)
scientific article
Language:
Current Data About Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens
(P31) (Q13442814)
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

(P304) 873-877
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

873-878

(P407) (Q1860)

(P433) 10
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

(P478) 10
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

(P577) Monday, November 1, 1999
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

+1999-11-00T00:00:00Z

(P1433) (Q4774128)
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

(P1476) "Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens" (language: en)
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

"Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens" (language: en)

(P2093) J-Y. Blay
(P1545) 1
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

I. Judson
(P1545) 2
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

S. Rodenhuis
(P1545) 3
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

C. Hermans
(P1545) 4
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

M. Smith
(P1545) 5
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

M. van Glabbeke
(P1545) 6
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

J. Verweij
(P1545) 7
(P248)
(P698) 10630354
(P813) Tuesday, July 25, 2017

other details
aliases Phase II study of raltitrexed (‘Tomudex’) for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens
description scientific article

External Links
(P356) 10.1097/00001813-199911000-00002
(P698) 10630354